PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health
CORTEXA TO BE THE LEADING SUPPLIER OF MDMA AND PSILOCYBIN IN AUSTRALIA
VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased…